share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

SEC announcement ·  Mar 27 07:05
Summary by Futu AI
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.